We found that phenformin significantly inhibits proliferation, migration, invasion, and EMT in ErbB2-overexpressing breast cancer cells and blocks tumor growth in a syngeneic mammary tumor model, which were associated with the inhibition of IGF1R stimulation. This evidence concerns the gene ERBB2 and breast cancer.